vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $11.1M, roughly 1.8× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -541.1%, a 552.0% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -5.6%). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -3.8%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
AGIO vs MDV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $11.1M |
| Net Profit | $-108.0M | $1.2M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 45.8% |
| Net Margin | -541.1% | 11.0% |
| Revenue YoY | 86.1% | -5.6% |
| Net Profit YoY | -11.9% | -22.0% |
| EPS (diluted) | $-1.86 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $11.1M | ||
| Q3 25 | $12.9M | $11.7M | ||
| Q2 25 | $12.5M | $11.8M | ||
| Q1 25 | $8.7M | $11.8M | ||
| Q4 24 | $10.7M | $11.7M | ||
| Q3 24 | $9.0M | $11.7M | ||
| Q2 24 | $8.6M | $11.4M | ||
| Q1 24 | $8.2M | $12.0M |
| Q4 25 | $-108.0M | $1.2M | ||
| Q3 25 | $-103.4M | $1.0M | ||
| Q2 25 | $-112.0M | $-2.0M | ||
| Q1 25 | $-89.3M | $829.0K | ||
| Q4 24 | $-96.5M | $1.6M | ||
| Q3 24 | $947.9M | $-587.0K | ||
| Q2 24 | $-96.1M | $1.3M | ||
| Q1 24 | $-81.5M | $3.7M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | 45.8% | ||
| Q3 25 | -907.4% | 41.4% | ||
| Q2 25 | -1020.1% | 9.8% | ||
| Q1 25 | -1222.0% | 40.2% | ||
| Q4 24 | -1165.3% | 45.4% | ||
| Q3 24 | -1146.9% | 42.0% | ||
| Q2 24 | -1228.3% | 44.6% | ||
| Q1 24 | -1124.3% | 55.6% |
| Q4 25 | -541.1% | 11.0% | ||
| Q3 25 | -803.1% | 9.0% | ||
| Q2 25 | -899.4% | -17.1% | ||
| Q1 25 | -1023.3% | 7.0% | ||
| Q4 24 | -899.6% | 13.3% | ||
| Q3 24 | 10574.7% | -5.0% | ||
| Q2 24 | -1115.7% | 11.6% | ||
| Q1 24 | -995.8% | 31.1% |
| Q4 25 | $-1.86 | $0.02 | ||
| Q3 25 | $-1.78 | $0.00 | ||
| Q2 25 | $-1.93 | $-0.32 | ||
| Q1 25 | $-1.55 | $-0.01 | ||
| Q4 24 | $-1.44 | $0.07 | ||
| Q3 24 | $16.22 | $-0.18 | ||
| Q2 24 | $-1.69 | $0.03 | ||
| Q1 24 | $-1.45 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $14.4M |
| Total DebtLower is stronger | — | $261.5M |
| Stockholders' EquityBook value | $1.2B | $162.7M |
| Total Assets | $1.3B | $476.5M |
| Debt / EquityLower = less leverage | — | 1.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $14.4M | ||
| Q3 25 | $92.7M | $8.3M | ||
| Q2 25 | $80.9M | $5.8M | ||
| Q1 25 | $79.0M | $6.2M | ||
| Q4 24 | $76.2M | $11.5M | ||
| Q3 24 | $253.7M | $6.8M | ||
| Q2 24 | $84.5M | $18.9M | ||
| Q1 24 | $118.8M | $18.4M |
| Q4 25 | — | $261.5M | ||
| Q3 25 | — | $279.7M | ||
| Q2 25 | — | $279.7M | ||
| Q1 25 | — | $279.7M | ||
| Q4 24 | — | $279.8M | ||
| Q3 24 | — | $279.7M | ||
| Q2 24 | — | $279.7M | ||
| Q1 24 | — | $279.6M |
| Q4 25 | $1.2B | $162.7M | ||
| Q3 25 | $1.3B | $164.8M | ||
| Q2 25 | $1.4B | $165.6M | ||
| Q1 25 | $1.5B | $171.1M | ||
| Q4 24 | $1.5B | $190.1M | ||
| Q3 24 | $1.6B | $186.3M | ||
| Q2 24 | $660.5M | $187.0M | ||
| Q1 24 | $743.9M | $188.0M |
| Q4 25 | $1.3B | $476.5M | ||
| Q3 25 | $1.4B | $499.6M | ||
| Q2 25 | $1.5B | $498.9M | ||
| Q1 25 | $1.6B | $506.8M | ||
| Q4 24 | $1.7B | $507.8M | ||
| Q3 24 | $1.8B | $507.4M | ||
| Q2 24 | $773.1M | $519.5M | ||
| Q1 24 | $849.7M | $522.5M |
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | — | 1.50× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $15.0M |
| Free Cash FlowOCF − Capex | $-97.3M | — |
| FCF MarginFCF / Revenue | -487.5% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | 12.34× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $15.0M | ||
| Q3 25 | $-88.2M | $4.1M | ||
| Q2 25 | $-77.1M | $3.9M | ||
| Q1 25 | $-111.5M | $3.0M | ||
| Q4 24 | $-133.2M | $18.2M | ||
| Q3 24 | $-84.2M | $5.1M | ||
| Q2 24 | $-72.6M | $4.7M | ||
| Q1 24 | $-99.9M | $3.0M |
| Q4 25 | $-97.3M | — | ||
| Q3 25 | $-89.7M | — | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | — | ||
| Q1 24 | $-100.0M | — |
| Q4 25 | -487.5% | — | ||
| Q3 25 | -696.5% | — | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | — | ||
| Q1 24 | -1221.2% | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 12.34× | ||
| Q3 25 | — | 3.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.68× | ||
| Q4 24 | — | 11.72× | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | 3.55× | ||
| Q1 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
